Bioactivity Screening of the Selected Turkish Marine Sponges and Three Compounds from Agelas oroides

Records of Natural Products

Volumn 6, Issue 4, 2012, Pages 356-367

  Orhan, Ilkay Erdogan ^a,b   Ozcelik, Berrin ^a   Konuklugil, Belma ^c   Putz, Annika ^d   Kaban, Ulku Gokcen ^c   Proksch, Peter ^d  

^a GAZI UNIVERSITY   (Turkey)

^b EASTERN MEDITERRANEAN UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d Institut für Pharmazeutische Biologie und Biotechnologie Duesseldorf   (Germany)

Author keywords

Anticholinesterase; Antimicrobial; Collection site; Marine sponge; Radical scavenger

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 25 HDROXY 24 METHYLCHOLESTEROL; 4,5 DIBROMOPYRROL 2 CARBOXYLIC ACID; ACETYLCHOLINESTERASE; AGELAS OROIDES EXTRACT; AMPICILLIN; AXINELLA CANNABINA EXTRACT; BUTYLATED HYDROXYANISOLE; DYSDEA AVARA EXTRACT; GALANTAMINE; GALLIC ACID; GENTAMICIN; IRCINIA FASCICULATA EXTRACT; IRCINIA SPINULOSA EXTRACT; IRCINIA VARIABILIS EXTRACT; MARINE SPONGE EXTRACT; NATURAL PRODUCT; OFLOXACIN; OROIDIN; SARCOTRAGUS SPINULOSUS EXTRACT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AGELAS OROIDES; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AXINELLA CANNABINA; BACILLUS SUBTILIS; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHOLINESTERASE INHIBITION; DYSDEA AVARA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IRCINIA FASCICULATA; IRCINIA SPINULOSA; IRCINIA VARIABILIS; KLEBSIELLA PNEUMONIAE; MEDITERRANEAN SEA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SARCOTRAGUS SPINULOSUS; SPONGE (PORIFERA); STAPHYLOCOCCUS AUREUS;

EID: 84865368041     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. G. Orhan, I. Orhan and B. Şener (2006). Recent developments in natural and synthetic drug research for Alzheimer's Disease, Lett. Drug Design Disc. 3, 268-274.
2. Clinical and Laboratory Standards Institute (CLSI; Formerly NCCLS) National Committee for Clinical Laboratory Standards (1996), Method for broth dilution antifungal susceptibility testing yeast; approved standard. M27-A, 15, 10, NCCLS, VA Medical Center, Tuscon.
3. Clinical and Laboratory Standards Institute (CLSI; Formerly NCCLS) National Committee for Clinical Laboratory Standards, Approved Standard (2002), NCCLS document M100-S12, NCCLS, 940 West Valley Road, Wayne, Pennsylvania 19087.
4. B. Özçelik, M. Aslan, I. Orhan and T. Karaoglu (2005). Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera L., Microbiol. Res. 160, 159-164.
5. M. S. Blois (1958). Antioxidant determinations by the use of a stable free radical, Nature 181, 1199-1200.
6. G. L. Ellman, K. D. Courtney, V. Andres and R. M. Featherstone (1961). A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7, 88-95.
7. F. S. Senol, I. Orhan, G. Yilmaz, M. Çiçek and B. Şener, (2010). Acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibition studies and antioxidant activities of thirty-three Scutellaria L. taxa from Turkey, Food Chem. Toxicol. 48, 781-788.
8. R. Fathi-Afshar, T. M. Allen, C. A. Krueger, D. A. Cook, A. S. Clanachan, R. Vriend, H. P. Baer and C. E. Cass (1989). Some pharmacological activities of novel adenine related compounds isolated from marine sponges Agelas mauritiana, Can. J. Physiol. Pharmacol. 67, 276-281.
9. B. Chanas, J. R. Pawlik, T. Lindel and W. Fenical (1996). Chemical defense of the Caribbean sponge Agelas clathroides, J. Exp. Marine Biol. Ecol. 208, 185-196.
10. E. Richelle-Maurer, M. J. De Kluijver, S. Feio, S. Gaudencio, H. Gaspar, R. Gomez, R. Tavares, G. Van De Vyver and R. W. M. Van Soest (2003). Localization and ecological significance of oroidin and sceptrin in the Caribbean sponge Agelas conifer, Biochem. System. Ecol. 31, 1073-1091.
11. P. Ciminiello, S. Magno, L. Mayol and V. Piccialli (1987). Cis-eudesmane nitrogenous metabolites from the marine sponges Axinella cannabina and Acanthella acuta, J. Nat. Prod. 50, 217-220.
12. A. Rudi, T. Yosief, M. Schleyer and Y. Kashman (1999). Several new isoprenoids from two marine sponges of the family Axinellidae, Tetrahedron. 55, 5555-5566.
13. I. Carletti, C. Long, C. Funel and P. Amade (2003). Yardenone A and B: New cytotoxic triterpenes from the Indian Ocean sponge Axinella cf. bidderi, J. Nat. Prod. 66, 25-29.
14. G. Cimino, S. De Stefano and L. Minale (1972). Further linear furanoterpenes from marine sponges, Tetrahedron 28, 5983-5991.
15. I. Erdogan, J. Tanaka, T. Higa and B. Şener (2000). Two new hydroquinone derivatives from two sponge species of the Aegean Sea, J. Chem. Soc. Pak. 22, 200-204.
16. A. De Giulio, S. De Rosa, G. Di Vincenzo and G. Strazzullo (1990). Further bioactive derivative of avarol from Dysidea avara, Tetrahedron. 46, 7971-7976.
17. L. Ferrandiz, M. J. Sanz, G. Bustos, M. Paya, J. M. Alcaraz and S. Dande-Rosa (1994). Avarol and avarone, two new anti-inflammatory agents of marine origin, Eur. J. Pharmacol. 253, 75-82.
18. P. A. Keifer, R. E. Schwartz, M. E. S. Koker, R. G. Hughes, D. Ritschof and K. L. Rinehart (1991). Bioactive bromopyrrole metabolites from the Caribbean sponge Agelas conifer, J. Org. Chem. 56, 2965-2975.
19. F. Cafieri, E. Fattorusso, A. Mangoni and O. Taglialatela-Scafati (1996). Clathramides, unique bromopyrrole alkaloids from the Caribbean sponge Agelas clatroides, Tetrahedron. 52, 13713-13720.
20. S. De Rosa, A. De Giulio and C. Iodice (1994). Biological effects of prenylated hydroquinones: Structure-activity relationship studies in antimicrobial, brine shrimp, and fish lethality assays, J. Nat. Prod. 57, 1711-1716.
21. R. W. Newbold, P. R. Jensen, W. Fenical and J. R. Pawlik (1999). Antimicrobial activity of Caribbean sponge extracts, Aquatic Microbiol. Ecol. 19, 279-284.
22. M. Tsoukatou, J. P. Maréchal, C. Hellio, I. Novaković, S. Tufegdzic, D. Sladić, M. J. Gašić and V. Roussis (2007). Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro-and macroorganisms, Molecules. 12, 1022-1034.
23. D. Tasdemir, B. Topaloglu, R. Perezzo, R. Brun, R. O'Neill, M. N. Carballeira, X. Zhang, P. J. Tonge, A. Lindenn and P. Rüedi (2007). Marine natural products from the Turkish marine sponge Agelas oroides that inhibit the enoyl reductases from Pasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli, Bioorg. Med. Chem. 15, 6834-6845.
24. I. Touati, K. Chaieb, A. Bakhrouf and K. Gaddour (2007). Screening of antimicrobial activity of marine sponge extracts collected from Tunisian coast, J. Mycol. Med. 17, 183-187.
25. N. L. Thakur and A. C. Anil (2000). Antibacterial activity of the sponge Ircinia ramosa: Importance of its surface-associated bacteria, J. Chem. Ecol. 26, 57-71.
26. l. Cariello, L. Zanetti, V. Cuomo and F. Vanzanella (1982). Antimicrobial activity of avarol, a sesquiterpenoid hydroquinone from the marine sponge, Comp. Biochem. Physiol. -B Biochem. Mol. Biol. 71, 281-283.
27. J. E. Thompson, R. P. Walker and D. J. Faulkner (1982). Screening and bioassays for biologically-active substances from forty marine sponge species from San Diego, California, USA. Marine Biol. 88, 11-21.
28. L. A. Tziveleka, A. P. Kourounakis, P. N. Kourounakis, V. Roussis and C. Vagias (2002). Antioxidant potential of natural and synthesised polyprenylated hydroquinones, Bioorg. Med. Chem. 10, 935-939.